The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Rare Neuromuscular Disorders Market - 2025-2033
US$ 3,400.00
Rare Neuromuscular Disorders Market reached US$ 6.13 Billion in 2024 and is expected to reach US$ 11.91 Billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The Rare Neu...
February 2026
54 pages
Australia Medical Cannabis Market Size, Share & Trends Analysis Report By Application, By Sources (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By Application (Cancer, Chronic Pain, Anxiety And Depression, Arthritis, Diabetes), And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The Australia medical cannabis market size was estimated at USD 595.12 million in 2025 and is projected to reach USD 1,637.44 million by 2033, growing at a CAGR of 12.85% from 2026 to 2033. This growt...
February 2026
100 pages
Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC, Others), By End-use (Medical Use, Recreational Use, Industrial Use), And Segment Forecasts, 2026 - 2033
US$ 3,950.00
The Australia legal cannabis market size was estimated at USD 862.31 million in 2025 and is anticipated to reach USD 3.05 billion by 2033, growing at a CAGR of 16.19% from 2026 to 2033. The industry i...
February 2026
100 pages
Cephalosporin Drugs Market - 2024-2031
US$ 3,400.00
Cephalosporin Drugs Marketis is growing with a CAGR of 2.60% during the forecast period 2026-2035. The Cephalosporin Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
February 2026
45 pages
